; and (ii) to reduce stigma associated with substance use disorders and treatment access among servicemembers and their military family members; (D) addressing concerns among servicemembers regarding the consequences of seeking or receiving care for a substance use disorder or overdose; (E) educating servicemembers on prevention strategies, tools to reduce or prevent overdose or substance use disorder, available mental and behavioral healthcare and substance use disorder care, including medication treatment for opioid use disorder, recovery support services, psychotherapy, inpatient rehabilitation services, and family support services; (F) potential supports for servicemembers in recovery; (G) improving continuity of care for substance use disorders from during the transition to veteran status; and (H) improving access to death investigation occurring outside the jurisdiction of the Armed Forces Medical Examiner System; (3) an identification of causes of fatal and non-fatal overdoses that are unique to servicemembers; (4) an identification of the barriers to care for substance use disorders for military family members of servicemembers and suggestions for additional data elements for the annual report required under section 2; (5) any other information that the Comptroller General of the United States considers appropriate with respect to the reduction of overdoses among servicemembers